Clinical Trial

Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

Name: Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy — clinical trial record (NCT05295407)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GenBx

Recruiting

View on ClinicalTrials.gov →

Summary

Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2022-03-16; most recent amendment 2026-02-24.

Trial Details

NCT Number	NCT05295407
Lead Sponsor	Endeavor Health Collaborators: Northwestern University, Johns Hopkins University, GoPath Diagnostics
Conditions	Prostate Cancer
Enrollment	1,000 participants
Start Date	2021-12-13
Primary Completion	2026-12-13 (estimated)
Study Completion	2027-12-13 (estimated)
Updated on ClinicalTrials.gov	2026-02-27